Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

From the outside looking in.

Mark Charny1

  • 1Translucency Ltd., 21 St. Georges Square, Worcester WR1 1HX. mark@translucency.co.uk

Journal of Public Health Medicine
|July 10, 2003
PubMed
Summary

Public health practitioners can benefit from engaging with pharmaceutical industry professionals. Allowing commercial interests to present their case, like in a legal setting, balances innovation with National Health Service (NHS) inertia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Costing bias in economic evaluations.

Journal of medical economicsยท2015
See all related articles

Area of Science:

  • Public Health
  • Pharmaceutical Industry
  • Health Policy

Background:

  • Public health practitioners often exhibit skepticism towards colleagues collaborating with the pharmaceutical industry.
  • This dynamic can hinder the advancement of public health initiatives and drug development.

Purpose of the Study:

  • To explore the potential benefits of collaboration between public health professionals and the pharmaceutical industry.
  • To reframe the relationship as a necessary component for balancing innovation and healthcare system inertia.

Main Methods:

  • Analogical reasoning comparing the legal system to industry-public health interactions.
  • Conceptual analysis of commercial interests within regulatory frameworks.

Main Results:

  • Public good can be advanced by allowing commercial entities to strongly advocate for their interests within established rules.
  • This approach mirrors legal proceedings where opposing sides present their cases within a defined structure.

Conclusions:

  • Collaboration, when regulated, can foster innovation in healthcare.
  • Balancing commercial interests with public health goals is crucial for overcoming National Health Service (NHS) inertia and driving progress.

Related Experiment Videos